Physician
One World Pediatrics
One World Pediatrics was paid $4.84M by Medicaid between Jan 2019 and Dec 2024, across 78 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 34% of everything it billed.
33Billing provider infoONE WORLD PEDIATRICS
LONGWOOD, FL 32750
LONGWOOD, FL 32750
33aNPI1467891531assigned 06/21/2013
33bProvider typePediatric Adolescent Medicine Physician
28Total paid$4.84M
24GClaims137,230
24DCodes billed78
24AFirst – last monthJan 2019 – Dec 2024
Compared with peers
Next to other Pediatric Adolescent Medicine Physician providers in Florida
Rank by total paid#2 of 56
Median peer was paid$221K
This provider vs. median22×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 17,404 | $689K | |
| 2020 | 15,919 | $641K | |
| 2021 | 17,285 | $872K | |
| 2022 | 23,382 | $1.13M | |
| 2023 | 39,443 | $946K | |
| 2024incomplete | 23,797 | $567K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 34% | 20,804 | 17,539 | $1.62M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 26% | 10,943 | 9,899 | $1.27M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 12% | 4,121 | 3,996 | $566K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 10% | 4,350 | 3,775 | $499K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.3% | 2,228 | 2,126 | $255K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.9% | 11,758 | 7,880 | $139K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.8% | 701 | 682 | $90K |
| 90461 | 1.2% | 7,866 | 4,158 | $56K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.0% | 6,215 | 3,160 | $51K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.0% | 2,455 | 2,359 | $50K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 778 | 632 | $46K |
| 90670 | <1% | 2,029 | 1,965 | $43K |
66 more codes
| 99460 | <1% | 457 | $41K | |
| 99188 | <1% | 2,575 | $23K | |
| 92552 | <1% | 586 | $17K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,773 | $17K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 173 | $6K |
| 90698 | <1% | 1,561 | $5K | |
| 99221 | <1% | 39 | $5K | |
| 90677 | <1% | 112 | $4K | |
| 99381 | <1% | 28 | $3K | |
| 99462 | <1% | 236 | $3K | |
| 96127 | <1% | 2,234 | $3K | |
| 90716 | <1% | 720 | $3K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 852 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 562 | $2K |
| 99383 | <1% | 12 | $2K | |
| 90651 | <1% | 136 | $2K | |
| 87807 | <1% | 296 | $2K | |
| 0071A | <1% | 63 | $2K | |
| 99050 | <1% | 197 | $2K | |
| 90696 | <1% | 103 | $1K | |
| 0072A | <1% | 57 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 166 | $1K |
| 99463 | <1% | 12 | $1K | |
| 99174 | <1% | 4,095 | $890.21 | |
| 90686 | <1% | 1,074 | $786.08 | |
| 90707 | <1% | 702 | $679.62 | |
| 90633 | <1% | 1,018 | $663.43 | |
| 90680 | <1% | 1,469 | $579.50 | |
| 90619 | <1% | 34 | $550.70 | |
| 99173 | <1% | 3,899 | $515.98 | |
| 96161 | <1% | 191 | $274.79 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 39 | $264.25 |
| 92587 | <1% | 14 | $161.65 | |
| 95115 | <1% | 166 | $146.02 | |
| 36416 | <1% | 310 | $117.66 | |
| 97802 | <1% | 918 | $110.42 | |
| 90744 | <1% | 1,086 | $84.01 | |
| 3074F | <1% | 2,408 | $75.00 | |
| 92551 | <1% | 3,474 | $65.55 | |
| 90656 | <1% | 15 | $50.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 146 | $44.34 |
| 0001A | <1% | 31 | $40.00 | |
| 0002A | <1% | 50 | $40.00 | |
| 99058 | <1% | 55 | $35.55 | |
| 81025 | <1% | 12 | $26.68 | |
| 1036F | <1% | 5,577 | $9.54 | |
| 99177 | <1% | 239 | $5.04 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 137 | $1.72 |
| 91307 | <1% | 143 | $0.41 | |
| 91300 | <1% | 58 | $0.01 | |
| 3008F | 0% | 4,640 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 56 | $0.00 |
| 90723 | 0% | 40 | $0.00 | |
| 99000 | 0% | 12 | $0.00 | |
| 1160F | 0% | 6,514 | $0.00 | |
| 3078F | 0% | 2,436 | $0.00 | |
| 90700 | 0% | 42 | $0.00 | |
| 1159F | 0% | 6,521 | $0.00 | |
| 3725F | 0% | 897 | $0.00 | |
| 90648 | 0% | 144 | $0.00 | |
| 90715 | 0% | 26 | $0.00 | |
| 90671 | 0% | 115 | $0.00 | |
| 96116 | 0% | 151 | $0.00 | |
| 90734 | 0% | 48 | $0.00 | |
| 81002 | 0% | 17 | $0.00 | |
| 90710 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAMBWANI, JAGDISH (CEO)